Literature DB >> 4972215

Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood.

L Verbist, A Gyselen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4972215     DOI： 10.1164/arrd.1968.98.6.923

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  28 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.

Authors:  A H Diacon; R F Patientia; A Venter; P D van Helden; P J Smith; H McIlleron; J S Maritz; P R Donald
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

Review 3.  Tuberculosis pharmacotherapy: strategies to optimize patient care.

Authors:  Carole D Mitnick; Bryan McGee; Charles A Peloquin
Journal:  Expert Opin Pharmacother       Date:  2009-02       Impact factor: 3.889

4.  Effect of rifampin on nasal carriage of Staphylococcus aureus.

Authors:  M A Sande; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

Review 5.  Influence of food and diet on gastrointestinal drug absorption: a review.

Authors:  P G Welling
Journal:  J Pharmacokinet Biopharm       Date:  1977-08

Review 6.  [Results of chemotherapy in tuberculosis].

Authors:  E Jancik
Journal:  Pneumonologie       Date:  1971

7.  [New paths of chemotherapy].

Authors:  G Urbanczik
Journal:  Pneumonologie       Date:  1971

8.  In vitro inhibition of Coccidioides immitis strains with amphotericin B plus rifampin.

Authors:  D Rifkind; E D Crowder; R N Hyland
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

9.  Susceptibility of mycobacteria to rifampin.

Authors:  C L Woodley; J O Kilburn; H L David; V A Silcox
Journal:  Antimicrob Agents Chemother       Date:  1972-10       Impact factor: 5.191

10.  Rifampicin-induced immune thrombocytopenia.

Authors:  M A Blajchman; R C Lowry; J E Pettit; P Stradling
Journal:  Br Med J       Date:  1970-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.